The rationale and approach to immunosuppressive therapy.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000145:classification; D000906:Antibodies / Q000494:pharmacology; D000917:Antibody Formation; D000941:Antigens / Q000032:analysis; D000939:Epitopes; D005246:Feedback; D007108:Immune Tolerance; D007112:Immunity, Maternally-Acquired; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007167:Immunotherapy; D008214:Lymphocytes / Q000276:immunology / Q000502:physiology; D008221:Lymphoid Tissue / Q000276:immunology / Q000502:physiology; D008264:Macrophages / Q000276:immunology; D013950:Thymus Gland / Q000276:immunology; D014181:Transplantation Immunology
D000903:Antibiotics, Antineoplastic; D000906:Antibodies; D000941:Antigens; D000939:Epitopes; D007166:Immunosuppressive Agents